Advertisement

Topics

Global Omega 3 Products Market Research Report 20112023 [Report Updated: 17102017] Prices from USD $3250

23:22 EDT 24 Oct 2017 | BioPortfolio Reports

Summary

Omega3 is an essential fatty acid EFA, also known as a polyunsaturated fatty acid PUFA.It is derived from both animal and plant sources, although Omega3 from fish oil is the most common supplemental form.

The global Omega 3 Products market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Omega 3

OmegaD3

Omega 369

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Aker BioMarine

Epax

Innovix Pharma

Crode

DSM

Nordic Naturals

Luhua Biomarine

Marine Ingredients

Cargill

Pharmavite

Ascenta Health

KD Pharma

Pharbio

Dow Chemical

GSK

Natrol

Carlson Laboratories

Gowell Pharma

ByHealth

OmegaBrite

Amway

NOW Foods

Optimum Nutrition

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Athletes and Lifters

Ordinary People

Others

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

AsiaPacific

North America

Europe

South America

Middle East Africa

Original Article: Global Omega 3 Products Market Research Report 20112023 [Report Updated: 17102017] Prices from USD $3250

NEXT ARTICLE

More From BioPortfolio on "Global Omega 3 Products Market Research Report 20112023 [Report Updated: 17102017] Prices from USD $3250"

Quick Search
Advertisement
 

Relevant Topic

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...